Research programme: oncolytic viruses - Genelux
Alternative Names: GLV-1h153; GLV-1h99Latest Information Update: 04 May 2020
At a glance
- Originator Genelux Corporation
- Class Diagnostic agents; Imaging agents; Oncolytic viruses
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Pancreatic cancer
Most Recent Events
- 08 Apr 2014 Preclinical trials in Prostate cancer in USA (Intratumoural) prior to April 2014
- 08 Apr 2014 Preclinical trials in Thyroid cancer in USA (Intratumoural) prior to April 2014
- 26 Sep 2011 Preclinical development is ongoing in USA